Dr Reddy's Laboratories (Dr Reddy's Laboratories) Pre-Tax Income : $868 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Dr Reddy's Laboratories's pretax income for the three months ended in Mar. 2024 was $193 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $868 Mil. Dr Reddy's Laboratories's pretax margin was 22.66%.

During the past 13 years, Dr Reddy's Laboratories's highest Pretax Margin was 25.79%. The lowest was 10.10%. And the median was 14.83%.

Dr Reddy's Laboratories Pre-Tax Income Historical Data

The historical data trend for Dr Reddy's Laboratories's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Pre-Tax Income Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

Get a 7-Day Free Trial

241.88

362.72

423.92

733.80

867.37

Dr Reddy's Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															161.12	224.54	230.34	219.29	193.35

Competitive Comparison of Dr Reddy's Laboratories's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Pre-Tax Income falls into.

Dr Reddy's Laboratories Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Dr Reddy's Laboratories's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	778.522	+	109.454	+	-20.609	+	0	+	0
	=	867

Dr Reddy's Laboratories's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	174.196	+	26.294	+	-7.143	+	0	+	0.0010000000000048
	=	193

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $868 Mil.

Dr Reddy's Laboratories (NYSE:RDY) Pre-Tax Income Explanation

Dr Reddy's Laboratories's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	193.348	/	853.154
	=	22.66%

During the past 13 years, Dr Reddy's Laboratories's highest Pretax Margin was 25.79%. The lowest was 10.10%. And the median was 14.83%.

Dr Reddy's Laboratories Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Pre-Tax Income

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.